Emtricitabine + tenofovir DF (PrEP)

🧮 Dose calculator

HIV pre-exposure prophylaxis (PrEP) · Regimen source: FDA Truvada · 2.5

• • Shown as the emtricitabine component (one 200/300 tablet). Confirm HIV-negative immediately before starting and at least every 3 months. FDA Truvada · 2.5FDA Truvada · Boxed Warning

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label: observational data have shown no increased risk of major birth defects. FDA Truvada · 8.1

  “Data on the use of TRUVADA during pregnancy from observational studies have shown no increased risk of major birth defects.”

• 🤱 BreastfeedingDangerous / avoid

  Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Truvada · 8.2

  “Women should not breastfeed if acute HIV-1 infection is suspected because of the risk of HIV-1 transmission to the infant.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Truvada · 8.4

  “Safety and effectiveness of Truvada for HIV-1 PrEP in pediatric patients weighing less than 35 kg have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Truvada · 8.5

  “Clinical trials of FTC, TDF, or TRUVADA did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.